Free Trial

biote (BTMD) Stock Price, News & Analysis

biote logo
$3.45 +0.08 (+2.37%)
Closing price 04:00 PM Eastern
Extended Trading
$3.44 -0.01 (-0.14%)
As of 06:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About biote Stock (NASDAQ:BTMD)

Key Stats

Today's Range
$3.39
$3.52
50-Day Range
$2.82
$4.55
52-Week Range
$2.76
$6.98
Volume
129,569 shs
Average Volume
158,919 shs
Market Capitalization
$170.57 million
P/E Ratio
3.83
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Moderate Buy

Company Overview

biote Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

BTMD MarketRank™: 

biote scored higher than 57% of companies evaluated by MarketBeat, and ranked 489th out of 960 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    biote has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Upside Potential

    biote has a consensus price target of $6.00, representing about 73.9% upside from its current price of $3.45.

  • Amount of Analyst Coverage

    biote has only been the subject of 1 research reports in the past 90 days.

  • Read more about biote's stock forecast and price target.
  • Earnings Growth

    Earnings for biote are expected to decrease by -28.00% in the coming year, from $0.75 to $0.54 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of biote is 5.52, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.39.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of biote is 5.52, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 74.93.

  • Read more about biote's valuation and earnings.
  • Percentage of Shares Shorted

    2.60% of the float of biote has been sold short.
  • Short Interest Ratio / Days to Cover

    biote has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in biote has recently decreased by 3.40%, indicating that investor sentiment is improving.
  • Dividend Yield

    biote does not currently pay a dividend.

  • Dividend Growth

    biote does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.60% of the float of biote has been sold short.
  • Short Interest Ratio / Days to Cover

    biote has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in biote has recently decreased by 3.40%, indicating that investor sentiment is improving.
  • News Sentiment

    biote has a news sentiment score of 1.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.94 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for biote this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, biote insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    24.00% of the stock of biote is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 21.68% of the stock of biote is held by institutions.

  • Read more about biote's insider trading history.
Receive BTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for biote and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BTMD Stock News Headlines

Insider Stock Buying Reaches US$1.01m On biote
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel
biote Corp. (BTMD) - Yahoo Finance
biote Corp. (BTMD) Q2 2025 Earnings Call Transcript
Biote Reports Second Quarter 2025 Financial Results
See More Headlines

BTMD Stock Analysis - Frequently Asked Questions

biote's stock was trading at $6.18 on January 1st, 2025. Since then, BTMD shares have decreased by 44.2% and is now trading at $3.45.

biote Corp. (NASDAQ:BTMD) posted its quarterly earnings data on Wednesday, August, 6th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.06 by $0.04. The company had revenue of $48.86 million for the quarter, compared to analyst estimates of $49.52 million. biote had a negative trailing twelve-month return on equity of 21.00% and a net margin of 15.73%.
Read the conference call transcript
.

biote's top institutional investors include Bandera Partners LLC (4.17%), Acadian Asset Management LLC (1.25%), Geode Capital Management LLC (1.13%) and Hillsdale Investment Management Inc. (0.77%). Insiders that own company stock include Guines Llc, Roystone Capital Management Lp, Stephen Mark Cone, Mary Elizabeth Conlon, Robert Charles Peterson and Samar Jagat Kamdar.
View institutional ownership trends
.

Shares of BTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that biote investors own include Meta Platforms (META), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Visa (V) and Netflix (NFLX).

Company Calendar

Last Earnings
8/06/2025
Today
9/15/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BTMD
CIK
1819253
Employees
194
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$4.00
Potential Upside/Downside
+73.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.90
Trailing P/E Ratio
3.83
Forward P/E Ratio
4.60
P/E Growth
N/A
Net Income
$3.16 million
Net Margins
15.73%
Pretax Margin
19.17%
Return on Equity
-21.00%
Return on Assets
18.26%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.98
Quick Ratio
0.74

Sales & Book Value

Annual Sales
$197.19 million
Price / Sales
0.86
Cash Flow
$0.78 per share
Price / Cash Flow
4.40
Book Value
($2.78) per share
Price / Book
-1.24

Miscellaneous

Outstanding Shares
49,440,000
Free Float
37,574,000
Market Cap
$170.57 million
Optionable
Not Optionable
Beta
1.19
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:BTMD) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners